Brome mosaic virus-like particles as siRNA nanocarriers for biomedical purposes

Scholarly Works

• Loredo-García, E.; Fournier, P. G. J.; Herrera-Hernandez, M. M.; Chauhan, K.; Rodriguez-Hernandez, A. G.; Vazquez-Duhalt, R.; Cadena-Nava, R. D. BMV and CCMV-Based Viral Nanoparticles for Delivery of N -Desmethyl-Tamoxifen as Treatment of Triple-Negative Breast Cancer. ACS Omega 2026. doi:10.1021/acsomega.5c11566
• Lozano‐Sanchez, E.; Moreno‐Gonzalez, M. A.; Merwaiss, F.; Steinmetz, N. F.; Daròs, J. Plant‐Produced Viral Nanoparticles Decorated with Nanobodies Against HER2 Improve Retention and Recruitment of Immune Cells in Solid Tumors. Advanced Healthcare Materials 2026. doi:10.1002/adhm.202505936
• Kim, D.; Duoto, B.; Varanasi, M.; Goldenfeld, G.; Steinmetz, N. F. Virus-like particles based on plant viruses and bacteriophages: emerging strategies for the delivery of nucleic acid therapeutics. Chemical science 2026, 17, 3908–3935. doi:10.1039/d5sc02211h
• Loredo-García, E.; Herrera-Hernandez, M. M.; Medrano-Villagómez, C.; Fournier, P. G. J.; Rodriguez-Hernandez, A. G.; Loredo-Tovías, M.; Ruiz-Garcia, J.; Dragnea, B.; Cadena-Nava, R. D. The solvent stability of bromovirus allows for delivery of hydrophobic chemotherapeutic drugs. Materials Advances 2026, 7, 469–483. doi:10.1039/d5ma00261c
• Shahgolzari, M.; Yavari, A.; Venkataraman, S.; Faija, M.; Hefferon, K. Plant Viral Vectors for Vaccine Development. Vaccines 2026, 14, 81. doi:10.3390/vaccines14010081
• Elbadri, K.; Fuscielo, M.; Hamdan, F.; Cheng, R.; Feola, S.; Bokharaie, H.; D'Amico, C.; Molinaro, G.; Correia, A.; Wang, S.; Jeltsch, M.; Cerullo, V.; Santos, H. A. Design and in vitro validation of Brome mosaic -virus-like particles for gene delivery and immunomodulation of melanoma. Materials today. Bio 2025, 36, 102693. doi:10.1016/j.mtbio.2025.102693
• Duran Meza, A. L.; Porak, S.-C.; Chapman, A.; Knobler, C. M.; Gelbart, W. M. How much genetic information in RNA form can be protected by a CCMV virus-like particle?. PloS one 2025, 20, e0336376. doi:10.1371/journal.pone.0336376
• Große, D. H. B.; Buhl, E. M.; Croon, A.; Schillberg, S.; Schuphan, J. High-yield on-demand production of tobacco mosaic virus-like particles using a plant-derived cell-free expression system. Frontiers in Nanotechnology 2025, 7. doi:10.3389/fnano.2025.1687889
• Martínez-Andrade, J. M.; Salgado-Bautista, D.; Ramirez-Acosta, K.; Cadena-Nava, R. D.; Riquelme, M. A practical protocol for correlative confocal fluorescence and transmission electron microscopy characterization of extracellular vesicles. Microbiology spectrum 2025, 13, e0302624. doi:10.1128/spectrum.03026-24
• Shan, Y.; Zhao, J.; Wei, K.; Jiang, P.; Shi, Y.; Chang, C.; Zheng, Y.; Zhao, F.; Li, Y.; He, B.; Zhou, M.; Liu, J.; Li, L.; Guo, S.; He, D. Multi-target RNA interference: A disruptive next-generation strategy for precision treatment of rheumatoid arthritis. International immunopharmacology 2025, 159, 114890. doi:10.1016/j.intimp.2025.114890
• Sitinjak, M. C.; Chen, J.-K.; Liu, P.-C.; Wang, C.-Y. Engineering in vitro-assembled beak and feather disease virus-like particles loaded with biomolecules. Biochemical and biophysical research communications 2025, 759, 151704. doi:10.1016/j.bbrc.2025.151704
• Mathur, S.; Chaturvedi, A.; Ranjan, R. Advances in RNAi-based nanoformulations: revolutionizing crop protection and stress tolerance in agriculture. Nanoscale advances 2025, 7, 1768–1783. doi:10.1039/d5na00044k
• Molina-Solís, J.; Gama, P.; Chauhan, K.; Rodríguez-Hernández, A. G.; Vazquez-Duhalt, R. Virus-based enzymatic nanoreactors with acid alpha-glucosidase for the potential treatment of Pompe disease. Materials Advances 2025, 6, 1613–1620. doi:10.1039/d4ma00943f
• Sun, D.; Liang, H.; Mu, Q.; Chu, C.; Liu, G.; Liu, C. Virus-inspired biogenic delivery system for advancing cancer therapy. Biomedical Technology 2025, 9, 100069. doi:10.1016/j.bmt.2025.100069
• Peralta-Cuevas, E.; Garcia-Atutxa, I.; Huerta-Saquero, A.; Villanueva-Flores, F. The Role of Plant Virus-like Particles in Advanced Drug Delivery and Vaccine Development: Structural Attributes and Application Potential. Viruses 2025, 17, 148. doi:10.3390/v17020148
• Hashim, G. M.; Shahgolzari, M.; Hefferon, K.; Yavari, A.; Venkataraman, S. Plant-Derived Anti-Cancer Therapeutics and Biopharmaceuticals. Bioengineering (Basel, Switzerland) 2024, 12, 7. doi:10.3390/bioengineering12010007
• Medrano-Villagómez, C.; Villagrana-Escareño, V.; Zárate-Romero, A.; Ayala, M.; Vazquez-Duhalt, R. Virus-Based Nanoreactor with Laccase Activity for Prodrug Activation. BioNanoScience 2024, 15. doi:10.1007/s12668-024-01777-3
• Sun, X.; Tian, T.; Lian, Y.; Cui, Z. Current Advances in Viral Nanoparticles for Biomedicine. ACS nano 2024, 18, 33827–33863. doi:10.1021/acsnano.4c13146
• Yang, R.; Zhang, B.; Fei, X.; Cong, S.; Zhao, S.; Zhou, T.; Shen, Y. Bioinspired micro- and nanostructured systems for cancer therapy. MedComm 2024, 5, e70025. doi:10.1002/mco2.70025
• Ramirez-Acosta, K.; Loredo-García, E.; Herrera-Hernandez, M. M.; Cadena-Nava, R. D. Plant Virus-Like Particles for RNA Delivery. Methods in molecular biology (Clifton, N.J.) 2024, 2822, 387–410. doi:10.1007/978-1-0716-3918-4_24

Explore citations to this article at